484 related articles for article (PubMed ID: 29493105)
21. Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults.
Osterberg KL; Boutagy NE; McMillan RP; Stevens JR; Frisard MI; Kavanaugh JW; Davy BM; Davy KP; Hulver MW
Obesity (Silver Spring); 2015 Dec; 23(12):2364-70. PubMed ID: 26466123
[TBL] [Abstract][Full Text] [Related]
22. A randomised placebo controlled trial of VSL#3
Chong PL; Laight D; Aspinall RJ; Higginson A; Cummings MH
BMC Gastroenterol; 2021 Apr; 21(1):144. PubMed ID: 33794784
[TBL] [Abstract][Full Text] [Related]
23. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.
Canfora EE; van der Beek CM; Hermes GDA; Goossens GH; Jocken JWE; Holst JJ; van Eijk HM; Venema K; Smidt H; Zoetendal EG; Dejong CHC; Lenaerts K; Blaak EE
Gastroenterology; 2017 Jul; 153(1):87-97.e3. PubMed ID: 28396144
[TBL] [Abstract][Full Text] [Related]
24. A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders.
Ligezka AN; Sonmez AI; Corral-Frias MP; Golebiowski R; Lynch B; Croarkin PE; Romanowicz M
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110187. PubMed ID: 33271210
[TBL] [Abstract][Full Text] [Related]
25. The combined effects of probiotics and restricted calorie diet on the anthropometric indices, eating behavior, and hormone levels of obese women with food addiction
Narmaki E; Borazjani M; Ataie-Jafari A; Hariri N; Doost AH; Qorbani M; Saidpour A
Nutr Neurosci; 2022 May; 25(5):963-975. PubMed ID: 33054635
[TBL] [Abstract][Full Text] [Related]
26. Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial.
Sepideh A; Karim P; Hossein A; Leila R; Hamdollah M; Mohammad E G; Mojtaba S; Mohammad S; Ghader G; Seyed Moayed A
J Am Coll Nutr; 2016 Aug; 35(6):500-505. PubMed ID: 26430826
[TBL] [Abstract][Full Text] [Related]
27. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease.
Yang YJ; Ni YH
J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S55-S61. PubMed ID: 30509561
[TBL] [Abstract][Full Text] [Related]
29. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota.
Alard J; Lehrter V; Rhimi M; Mangin I; Peucelle V; Abraham AL; Mariadassou M; Maguin E; Waligora-Dupriet AJ; Pot B; Wolowczuk I; Grangette C
Environ Microbiol; 2016 May; 18(5):1484-97. PubMed ID: 26689997
[TBL] [Abstract][Full Text] [Related]
30. Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol.
Silva-Sperb AS; Moraes HA; de Moura BC; Alves BC; Bruch-Bertani JP; Azevedo VZ; Dall'Alba V
Trials; 2019 Oct; 20(1):580. PubMed ID: 31601229
[TBL] [Abstract][Full Text] [Related]
31. Inulin-type fructans and whey protein both modulate appetite but only fructans alter gut microbiota in adults with overweight/obesity: A randomized controlled trial.
Reimer RA; Willis HJ; Tunnicliffe JM; Park H; Madsen KL; Soto-Vaca A
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28730743
[TBL] [Abstract][Full Text] [Related]
32. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
33. Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits.
López-Contreras BE; Morán-Ramos S; Villarruel-Vázquez R; Macías-Kauffer L; Villamil-Ramírez H; León-Mimila P; Vega-Badillo J; Sánchez-Muñoz F; Llanos-Moreno LE; Canizalez-Román A; Del Río-Navarro B; Ibarra-González I; Vela-Amieva M; Villarreal-Molina T; Ochoa-Leyva A; Aguilar-Salinas CA; Canizales-Quinteros S
Pediatr Obes; 2018 Jun; 13(6):381-388. PubMed ID: 29388394
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: A randomized, double-blind, placebo-controlled, multicenter trial and in vitro study.
Kim CS; Jung S; Hwang GS; Shin DM
Clin Nutr; 2023 Jun; 42(6):1025-1033. PubMed ID: 37150125
[TBL] [Abstract][Full Text] [Related]
35. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
[TBL] [Abstract][Full Text] [Related]
36. Relations of gut liver axis components and gut microbiota in obese children with fatty liver: A pilot study.
Pierri L; Saggese P; Guercio Nuzio S; Troisi J; Di Stasi M; Poeta M; Savastano R; Marchese G; Tarallo R; Massa G; Ciccone V; Ziegenhardt D; Cavallo P; Bergheim I; Weisz A; Vajro P
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):387-390. PubMed ID: 29773420
[No Abstract] [Full Text] [Related]
37. The safety profile of probiotic VSL#3®. A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials.
Panetta V; Bacchieri A; Papetti S; De Stefani E; Navarra P
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):963-973. PubMed ID: 32017005
[TBL] [Abstract][Full Text] [Related]
38. Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial.
Szulińska M; Łoniewski I; van Hemert S; Sobieska M; Bogdański P
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29914095
[TBL] [Abstract][Full Text] [Related]
39. Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms.
Chahwan B; Kwan S; Isik A; van Hemert S; Burke C; Roberts L
J Affect Disord; 2019 Jun; 253():317-326. PubMed ID: 31078831
[TBL] [Abstract][Full Text] [Related]
40. Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial.
Escouto GS; Port GZ; Tovo CV; Fernandes SA; Peres A; Dorneles GP; Houde VP; Varin TV; Pilon G; Marette A; Buss C
J Nutr; 2023 Jul; 153(7):1984-1993. PubMed ID: 37225124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
